{"id":"W4308432482","doi":"10.1016/j.lungcan.2022.11.004","title":"Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Pfizer","keywords":"Crizotinib; Medicine; Lung cancer; Nausea; Internal medicine; Quality of life (healthcare); ALK inhibitor; Oncology; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002804833,0.000749655,0.001622178,0.0002202988,0.0002919181,0.0006510805,0.0006087425,0.0007989957,0.00288524],"category_scores_gemma":[0.002920039,0.0003022492,0.002444012,0.0002538508,0.0005471266,0.0004371002,0.0003381538,0.001591645,0.0002354472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001134789,"about_ca_system_score_gemma":0.001514724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00195117,"about_ca_topic_score_gemma":0.005939107,"domain_scores_codex":[0.9987996,0.0007577584,0.00006517833,0.0001347923,0.0001468549,0.00009599188],"domain_scores_gemma":[0.9980881,0.000593341,0.0006803243,0.0001333962,0.0001499773,0.0003547731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9526607,0.002773596,0.009300279,0.0008158697,0.00347527,0.00003295165,0.00008033583,0.00173066,0.003244205,0.0000874353,0.001654145,0.02414452],"study_design_scores_gemma":[0.7759609,0.145199,0.0675908,0.00008889284,0.004303386,0.0001350784,0.00006241374,0.002788887,0.001586208,0.0002228462,0.002007819,0.0000536463],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936153,0.0030133,0.0001954898,0.0002216591,0.00005644994,0.0008346997,0.001311917,0.00002921605,0.0007219306],"genre_scores_gemma":[0.9936634,0.0009531124,0.0006704359,0.0003677552,0.00007976987,0.001235354,0.0024486,0.00001033543,0.0005712556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00288524,"threshold_uncertainty_score":0.01483351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01798761460819827,"score_gpt":0.3551372383528579,"score_spread":0.3371496237446596,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}